These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18781572)

  • 1. alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors.
    Asso V; Ghilardi E; Bertini S; Digiacomo M; Granchi C; Minutolo F; Rapposelli S; Bortolato A; Moro S; Macchia M
    ChemMedChem; 2008 Oct; 3(10):1530-4. PubMed ID: 18781572
    [No Abstract]   [Full Text] [Related]  

  • 2. Fragment-based discovery and optimization of BACE1 inhibitors.
    Madden J; Dod JR; Godemann R; Kraemer J; Smith M; Biniszkiewicz M; Hallett DJ; Barker J; Dyekjaer JD; Hesterkamp T
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5329-33. PubMed ID: 20656487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment-based discovery of BACE1 inhibitors using functional assays.
    Godemann R; Madden J; Krämer J; Smith M; Fritz U; Hesterkamp T; Barker J; Höppner S; Hallett D; Cesura A; Ebneth A; Kemp J
    Biochemistry; 2009 Nov; 48(45):10743-51. PubMed ID: 19799414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, SAR, and X-ray structure of human BACE-1 inhibitors with cyclic urea derivatives.
    Park H; Min K; Kwak HS; Koo KD; Lim D; Seo SW; Choi JU; Platt B; Choi DY
    Bioorg Med Chem Lett; 2008 May; 18(9):2900-4. PubMed ID: 18434152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.
    Piazzi L; Cavalli A; Colizzi F; Belluti F; Bartolini M; Mancini F; Recanatini M; Andrisano V; Rampa A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):423-6. PubMed ID: 17998161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
    Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
    Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
    Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors.
    Malamas MS; Erdei J; Gunawan I; Barnes K; Johnson M; Hui Y; Turner J; Hu Y; Wagner E; Fan K; Olland A; Bard J; Robichaud AJ
    J Med Chem; 2009 Oct; 52(20):6314-23. PubMed ID: 19757823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of highly active Alzheimer's beta-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability.
    Kimura T; Shuto D; Hamada Y; Igawa N; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2005 Jan; 15(1):211-5. PubMed ID: 15582441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
    Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.
    Tagad HD; Hamada Y; Nguyen JT; Hidaka K; Hamada T; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2011 Sep; 19(17):5238-46. PubMed ID: 21803585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbazole-containing arylcarboxamides as BACE1 inhibitors.
    Bertini S; Asso V; Ghilardi E; Granchi C; Manera C; Minutolo F; Saccomanni G; Bortolato A; Mason J; Moro S; Macchia M
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6657-61. PubMed ID: 21986588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
    Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors.
    Xu YZ; Yuan S; Bowers S; Hom RK; Chan W; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Yan J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
    Bioorg Med Chem Lett; 2013 May; 23(10):3075-80. PubMed ID: 23570791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
    Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of (3S,4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities.
    De Tran Q; Bepary S; Lee GH; Cho H; Park WK; Lim HJ
    Bioorg Med Chem Lett; 2016 Jan; 26(1):51-4. PubMed ID: 26608551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1.
    Barrow JC; Rittle KE; Ngo PL; Selnick HG; Graham SL; Pitzenberger SM; McGaughey GB; Colussi D; Lai MT; Huang Q; Tugusheva K; Espeseth AS; Simon AJ; Munshi SK; Vacca JP
    ChemMedChem; 2007 Jul; 2(7):995-9. PubMed ID: 17458843
    [No Abstract]   [Full Text] [Related]  

  • 18. Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors.
    Malamas MS; Erdei J; Gunawan I; Turner J; Hu Y; Wagner E; Fan K; Chopra R; Olland A; Bard J; Jacobsen S; Magolda RL; Pangalos M; Robichaud AJ
    J Med Chem; 2010 Feb; 53(3):1146-58. PubMed ID: 19968289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
    Kakizawa T; Hidaka K; Hamada D; Yamaguchi R; Uemura T; Kitamura H; Tagad HD; Hamada T; Ziora Z; Hamada Y; Kimura T; Kiso Y
    J Pept Sci; 2010 Jun; 16(6):257-62. PubMed ID: 20474036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KMI-358 and KMI-370, highly potent and small-sized BACE1 inhibitors containing phenylnorstatine.
    Kimura T; Shuto D; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Hattori C; Asai M; Kitazume S; Saido TC; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1527-31. PubMed ID: 15006396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.